Stay updated with breaking news from Marriott Larson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Needham & Company LLC reiterated their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $17.00 price target on the stock. Other equities analysts have also recently issued reports about the company. Morgan Stanley began coverage on Recursion Pharmaceuticals in […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price dropped 8% during mid-day trading on Wednesday . The company traded as low as $12.64 and last traded at $12.70. Approximately 818,678 shares traded hands during trading, a decline of 73% from the average daily volume of 3,030,443 shares. The stock had previously closed at […]
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) fell 8% during trading on Wednesday . The stock traded as low as $12.64 and last traded at $12.70. 818,678 shares were traded during mid-day trading, a decline of 73% from the average session volume of 3,030,443 shares. The stock had previously closed at $13.81. […]
Nikko Asset Management Americas Inc. boosted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 10.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 501,977 shares of the company’s stock after buying an additional 47,455 shares during the […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares gapped down prior to trading on Thursday after an insider sold shares in the company. The stock had previously closed at $15.86, but opened at $15.36. Recursion Pharmaceuticals shares last traded at $15.76, with a volume of 1,927,818 shares changing hands. Specifically, COO Tina Marriott Larson […]